Delivery Order SPE2DB22D1017-SPE2DB25FG8KP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $31,897.20 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This non-competitive, firm fixed-price delivery order represents a single-line item pharmaceutical procurement supporting federal medical supply needs. The award was issued without a set-aside designation and will be performed at the contractor's facility...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count units) valued at $1,047.86 on September 3, 2025, with completion scheduled for September 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is performed from the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $28,591.14 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Concerta ER Tablets 36mg. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract requires completion by July 28, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Concerta ER 36 mg tablets (100-count units) valued at $11,257.85. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by July 15, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $7,185.49 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count units) on September 11, 2025, with completion scheduled for September 12, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Concerta ER 36 mg tablets (100-count units) valued at $5,783.47, with delivery completion by September 10, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The prime contractor, headquartered in...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Concerta ER Tablets 36mg with a ceiling value of $15,818.06. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle and involves no set-aside designation. The award was made competitively and will be performed at the...
- On September 16, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $23,558.87 to AmerisourceBergen Drug Corp for the supply of Concerta ER (extended-release) 36 mg tablets. This competitive, firm fixed-price delivery order, which carries no set-aside designation, is scheduled for completion by September 17, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Concerta ER 18 mg tablets in quantities of 100 units, with a ceiling value of $36,401.68. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement. The order is scheduled for completion by August 25, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,325.78 on August 5, 2025, for the supply of Concerta ER 36 mg tablets (100 count). This firm fixed-price delivery order, with an ultimate completion date of August 6, 2025, represents a non-competitive set-aside contract executed under AmerisourceBergen's existing federal contract vehicle. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken,...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG8KPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Concerta ER 36 mg tablets (100-count packaging) valued at $2,786.94. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, is scheduled for completion by July 30, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction supporting federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. As a primary pharmaceutical distributor for federal military and veteran healthcare systems, AmerisourceBergen leverages this comprehensive contract vehicle to supply a broad portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic areas to support the Defense Health Agency and other government healthcare entities globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 7/29/25 |